The legal victory represents a significant reduction in the risk profile of the company. The company's fending off of this major threat is likely to lift sentiment for the entire large-cap pharmaceutical group through the remainder of 2005.
They got slammed. The credibility of this company has been damaged and will continue to be so for some time until they can deliver.